- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Recently Accepted Articles ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 597086, 6 pages
Substance P Signaling Contributes to Granuloma Formation in Taenia crassiceps Infection, a Murine Model of Cysticercosis
1Section of Infectious Disease, Department of Medicine, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
2Division of Gastroenterology, Tufts New England Medical Center, 750 Washington St., Box 233, Boston, MA 02111, USA
Received 8 August 2009; Revised 19 October 2009; Accepted 4 November 2009
Academic Editor: Luis I. Terrazas
Copyright © 2010 Armandina Garza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- H. H. García, C. A. W. Evans, T. E. Nash, et al., “Current consensus guidelines for treatment of neurocysticercosis,” Clinical Microbiology Reviews, vol. 15, no. 4, pp. 747–756, 2002.
- A. Carpio, “Neurocysticercosis: an update,” The Lancet Infectious Diseases, vol. 2, no. 12, pp. 751–762, 2002.
- N. E. Bharucha, “Epidemiology of epilepsy in India,” Epilepsia, vol. 44, supplement 1, pp. 9–11, 2003.
- P. R. M. de Bittencourt, B. Adamolekum, N. Bharucha, et al., “Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immunologic diagnosis, economics, and therapy,” Epilepsia, vol. 37, no. 11, pp. 1128–1137, 1996.
- P. Jallon, “Epilepsy in developing countries,” Epilepsia, vol. 38, no. 10, pp. 1143–1151, 1997.
- V. Rajshekhar, D. D. Joshi, N. Q. Doanh, N. van De, and Z. Xiaonong, “Taenia solium taeniosis/cysticercosis in Asia: epidemiology, impact and issues,” Acta Tropica, vol. 87, no. 1, pp. 53–60, 2003.
- A. L. Sánchez, J. Lindbäck, P. M. Schantz, et al., “A population-based, case-control study of Taenia solium taeniasis and cysticercosis,” Annals of Tropical Medicine and Parasitology, vol. 93, no. 3, pp. 247–258, 1999.
- S. Ong, D. A. Talan, G. J. Moran, et al., “Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments,” Emerging Infectious Diseases, vol. 8, no. 6, pp. 608–613, 2002.
- F. J. Sorvillo, S. H. Waterman, F. O. Richards, and P. M. Schantz, “Cysticercosis surveillance: locally acquired and travel-related infections and detection of intestinal tapeworm carriers in Los Angeles County,” American Journal of Tropical Medicine and Hygiene, vol. 47, no. 3, pp. 365–371, 1992.
- B. I. Restrepo, P. Llaguno, M. A. Sandoval, J. A. Enciso, and J. M. Teale, “Analysis of immune lesions in neurocysticercosis patients: central nervous system response to helminth appears Th1-like instead of Th2,” Journal of Neuroimmunology, vol. 89, no. 1-2, pp. 64–72, 1998.
- O. F. Villa and R. E. Kuhn, “Mice infected with the larvae of Taenia crassiceps exhibit a Th2-like immune response with concomitant anergy and downregulation of Th1-associated phenomena,” Parasitology, vol. 112, no. 6, pp. 561–570, 1996.
- C. Larralde, R. M. Montoya, J. Sotelo, et al., “Murine T. crassiceps antigens in immunodiagnosis of T. solium human neurocysticercosis, T. saginata bovine cysticercosis, and human E. granulosus hydatidosis,” Bulletin de la Societe Francaise de Parasitology, vol. 8, p. S8B, 1990.
- O. Villa and R. Kuhn, “Antigenic and immunogenic analysis of Taenia crassiceps and Taenia solium using sera from their natural intermediate hosts,” ASM Bulletin, vol. 39, pp. 99–103, 1991.
- J. Kunz, B. Kalinna, V. Watschke, and E. Geyer, “Taenia crassiceps metacestode vesicular fluid antigens shared with the Taenia solium larval stage and reactive with serum antibodies from patients with neurocysticercosis,” Zentralblatt für Bakteriologie, vol. 271, no. 4, pp. 510–520, 1989.
- E. Sciutto, G. Fragoso, M. Baca, V. De la Cruz, L. Lemus, and E. Lamoyi, “Depressed T-cell proliferation associated with susceptibility to experimental Taenia crassiceps infection,” Infection and Immunity, vol. 63, no. 6, pp. 2277–2281, 1995.
- A. Garza, J. Weinstock, and P. Robinson, “Absence of the SP/SP receptor circuitry in the substance P-precursor knockout mice or SP receptor, neurokinin (NK)1 knockout mice leads to an inhibited cytokine response in granulomas associated with murine Taenia crassiceps infection,” Journal of Parasitology, vol. 94, no. 6, pp. 1253–1258, 2008.
- P. Robinson, A. C. White, D. E. Lewis, J. Thornby, E. David, and J. Weinstock, “Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis,” Infection and Immunity, vol. 70, no. 8, pp. 4534–4538, 2002.
- S. Patil, J. Actor, P. Robinson, S. Baig, and A. J. White, “Proinflammatory cytokines in murine cysticercal granulomas,” in Proceedings of the 48th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH '99), Washington, DC, USA, November-December 1999.
- T. S. Fröde-Saleh, J. B. Calixto, and Y. S. Medeiros, “Analysis of the inflammatory response induced by substance P in the mouse pleural cavity,” Peptides, vol. 20, no. 2, pp. 259–265, 1999.
- A. Hegde and M. Bhatia, “Neurogenic inflammation in acute pancreatitis,” Journal of the Pancreas, vol. 6, no. 5, pp. 417–421, 2005.
- K. A. Haines, S. L. Kolasinski, B. N. Cronstein, J. Reibman, L. I. Gold, and G. Weissmann, “Chemoattraction of neutrophils by substance P and transforming growth factor-1 is inadequately explained by current models of lipid remodeling,” The Journal of Immunology, vol. 151, no. 3, pp. 1491–1499, 1993.
- C. M. Kahler, B. A. Sitte, N. Reinisch, and C. J. Wiedermann, “Stimulation of the chemotactic migration of human fibroblastsfd by substance P,” European Journal of Pharmacology, vol. 249, no. 3, pp. 281–286, 1993.
- P. Schratzberger, N. Reinisch, W. M. Prodinger, et al., “Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells,” The Journal of Immunology, vol. 158, no. 8, pp. 3895–3901, 1997.
- C. H. Smith, J. N. W. N. Barker, R. W. Morris, D. M. MacDonald, and T. H. Lee, “Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin,” The Journal of Immunology, vol. 151, no. 6, pp. 3274–3282, 1993.
- B. Veronesi, J. D. Carter, R. B. Devlin, S. A. Simon, and M. Oortgiesen, “Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line,” Neuropeptides, vol. 33, no. 6, pp. 447–456, 1999.
- K. Lieb, H. Schaller, J. Bauer, M. Berger, K. Schulze-Osthoff, and B. L. Fiebich, “Substance P and histamine induce interleukin-6 expression in human astrocytoma cells by a mechanism involving protein kinase C and nuclear factor-IL-6,” Journal of Neurochemistry, vol. 70, no. 4, pp. 1577–1583, 1998.
- B. L. Fiebich, S. Schleicher, R. D. Butcher, A. Craig, and K. Lieb, “The neuropeptide substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-B,” The Journal of Immunology, vol. 165, no. 10, pp. 5606–5611, 2000.
- M. C. Cuesta, L. Quintero, H. Pons, and H. Suarez-Roca, “Substance P and calcitonin gene-related peptide increase IL-1, IL-6 and TNF secretion from human peripheral blood mononuclear cells,” Neurochemistry International, vol. 40, no. 4, pp. 301–306, 2002.
- M. Lotz, J. H. Vaughan, and D. A. Carson, “Effect of neuropeptides on production of inflammatory cytokines by human monocytes,” Science, vol. 241, no. 4870, pp. 1218–1221, 1988.
- A. M. Blum, A. Metwali, M. Kim-Miller, et al., “The substance P receptor is necessary for a normal granulomatous response in murine schistosomiasis mansoni,” The Journal of Immunology, vol. 162, no. 10, pp. 6080–6085, 1999.
- D. L. Boros, “The role of cytokines in the formation of the schistosome egg granuloma,” Immunobiology, vol. 191, no. 4-5, pp. 441–450, 1994.
- K. Kasahara, K. Kobayashi, Y. Shikama, et al., “The role of monokines in granuloma formation in mice: the ability of interleukin 1 and tumor necrosis factor- to induce lung granulomas,” Clinical Immunology and Immunopathology, vol. 51, no. 3, pp. 419–425, 1989.
- H. M. S. Algood, P. L. Lin, and J. L. Flynn, “Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis,” Clinical Infectious Diseases, vol. 41, supplement 3, pp. S189–S193, 2005.
- A. A. Parikh, A. L. Salzman, C. D. Kane, J. E. Fischer, and P.-O. Hasselgren, “IL-6 production in human intestinal epithelial cells following stimulation with IL-1 is associated with activation of the transcription factor NF-B,” Journal of Surgical Research, vol. 69, no. 1, pp. 139–144, 1997.
- K. Kurokouchi, F. Kambe, K. Yasukawa, et al., “TNF- increases expression of IL-6 and ICAM-1 genes through activation of NF-B in osteoblast-like ROS17/2.8 cells,” Journal of Bone and Mineral Research, vol. 13, no. 8, pp. 1290–1299, 1998.
- J. V. Weinstock, A. Blum, J. Walder, and R. Walder, “Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P,” The Journal of Immunology, vol. 141, no. 3, pp. 961–966, 1988.
- C. A. Maggi, “The effects of tachykinins on inflammatory and immune cells,” Regulatory Peptides, vol. 70, no. 2-3, pp. 75–90, 1997.
- W.-Z. Ho, J.-P. Lai, X.-H. Zhu, M. Uvaydova, and S. D. Douglas, “Human monocytes and macrophages express substance P and neurokinin-1 receptor,” The Journal of Immunology, vol. 159, no. 11, pp. 5654–5660, 1997.
- T. Goode, J. O'Connell, C. Sternini, et al., “Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononulear cells: molecular quantitation and localization,” The Journal of Immunology, vol. 161, no. 5, pp. 2232–2240, 1998.
- G. A. Cook, D. Elliott, A. Metwali, et al., “Molecular evidence that granuloma T lymphocytes in murine schistosomiasis mansoni express an authentic substance P (NK-1) receptor,” The Journal of Immunology, vol. 152, no. 4, pp. 1830–1835, 1994.
- F. C. Martin, A. C. Charles, M. J. Sanderson, and J. E. Merrill, “Substance P stimulates IL-1 production by astrocytes via intracellular calcium,” Brain Research, vol. 599, no. 1, pp. 13–18, 1992.
- A. Azzolina, A. Bongiovanni, and N. Lampiasi, “Substance P induces TNF- and IL-6 production through NFB in peritoneal mast cells,” Biochimica et Biophysica Acta, vol. 1643, no. 1–3, pp. 75–83, 2003.
- A. Azzolina, P. Guarneri, and N. Lampiasi, “Involvement of p38 and JNK MAPKs pathways in substance P-induced production of TNF- by peritoneal mast cells,” Cytokine, vol. 18, no. 2, pp. 72–80, 2002.
- A. Metwali, A. M. Blum, D. E. Elliott, T. Setiawan, and J. V. Weinstock, “Cutting edge: hemokinin has substance P-like function and expression in inflammation,” The Journal of Immunology, vol. 172, no. 11, pp. 6528–6532, 2004.
- J. M. Davis and L. Ramakrishnan, “The role of the granuloma in expansion and dissemination of early tuberculous infection,” Cell, vol. 136, no. 1, pp. 37–49, 2009.
- J. L. Stringer, L. M. Marks, A. C. White Jr., and P. Robinson, “Epileptogenic activity of granulomas associated with murine cysticercosis,” Experimental Neurology, vol. 183, no. 2, pp. 532–536, 2003.
- H. Liu, A. M. Mazarati, H. Katsumori, R. Sankar, and C. G. Wasterlain, “Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 9, pp. 5286–5291, 1999.